Evolution of neoplastic cell lineages in Barrett oesophagus

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Nature Genetics

• Publication date

  1999-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/8816PMID 10319873PMCID PMC1559997
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Multifocal renal cell carcinoma: evidence for a common clonal origin.

  1998cited by this paper
• Genetic alterations in Barrett esophagus and adenocarcinomas of the esophagus and esophagogastric junction region.

  1998cited by this paper
• Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer.

  1997cited by this paper
• Clonal genetic alterations in the lungs of current and former smokers.

  1997cited by this paper
• p16INK4a promoter is hypermethylated at a high frequency in esophageal adenocarcinomas.

  1997cited by this paper
• Poster 7: A Genetic Progression Model for Head and Neck Cancer: Implications for Field Cancerization

  1996cited by this paper
• Allelic loss and mutational analysis of the DPC4 gene in esophageal adenocarcinoma.

  1996cited by this paper
• Determination of the frequency of loss of heterozygosity in esophageal adenocarcinoma by cell sorting, whole genome amplification and microsatellite polymorphisms.

  1996cited by this paper
• Multiple head and neck tumors: evidence for a common clonal origin.

  1996cited by this paper
• 17p (p53) allelic losses, 4N (G2/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus.

  1996cited by this paper
• Allelic loss of 9p21 and mutation of the CDKN2/p16 gene develop as early lesions during neoplastic progression in Barrett's esophagus.

  1996cited by this paper
• Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus.

  1995cited by this paper
• Low incidence of significant dysplasia in a successful endoscopic surveillance program of patients with ulcerative colitis.

  1995cited by this paper
• Microallelotyping defines the sequence and tempo of alleiic losses at tumour suppressor gene loci during colorectal cancer progression

  1995cited by this paper
• p53 mutations in Barrett's adenocarcinoma and high-grade dysplasia.

  1994cited by this paper
• Molecular genetic changes found in human lung cancer and its precursor lesions.

  1994cited by this paper
• 17p allelic losses in diploid cells of patients with Barrett's esophagus who develop aneuploidy.

  1994cited by this paper
• An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus.

  1993cited by this paper
• Clonal ordering of 17p and 5q allelic losses in Barrett dysplasia and adenocarcinoma.

  1993cited by this paper
• Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort.

  1992cited by this paper
• Clonal expansion of p53 mutant cells is associated with brain tumour progression

  1992cited by this paper
• Distribution of aneuploid cell populations in ulcerative colitis with dysplasia or cancer.

  1991cited by this paper
• Gastric precancerous process in a high risk population: cohort follow-up.

  1990cited by this paper
• A genetic model for colorectal tumorigenesis.

  1990cited by this paper
• Progression to cancer in Barrett's esophagus is associated with genomic instability.

  1989cited by this paper
• Barrett's esophagus. Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma.

  1987cited by this paper
• Endoscopic surveillance for patients with Barrett esophagus: does the cancer risk justify the practice?

  1987cited by this paper
• Risk of colorectal cancer in adenoma‐bearing individuals within a defined population

  1986cited by this paper
• The clonal evolution of tumor cell populations.

  1976cited by this paper

• DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML, but Is Associated With Increased Leukemia Stem Cell Frequency.

  2025cites this paper
• The biology and therapeutic implications of heterogeneity in Barrett oesophagus and oesophageal adenocarcinoma

  2025cites this paper
• The evolutionary theory of cancer: challenges and potential solutions

  2024cites this paper
• Single nucleus DNA sequencing of flow sorted archived frozen and formalin fixed paraffin embedded solid tumors

  2024cites this paper
• DNMT3AR882H Is Not Required for Disease Maintenance in Primary Human AML, but Is Associated With Increased Leukemia Stem Cell Frequency

  2024cites this paper
• Context-dependent effects of CDKN2A and other 9p21 gene losses during the evolution of esophageal cancer

  2024cites this paper
• Genomic signatures of past and present chromosomal instability in Barrett’s esophagus and early esophageal adenocarcinoma

  2023cites this paper
• Deterministic evolution and stringent selection during preneoplasia

  2023cites this paper
• Genomic signatures of past and present chromosomal instability in the evolution of Barrett’s esophagus to esophageal adenocarcinoma

  2023cites this paper
• High‐Resolution Multiparameter DNA Flow Cytometry for Accurate Ploidy Assessment and the Detection and Sorting of Tumor and Stromal Subpopulations from Paraffin‐Embedded Tissues

  2023cites this paper
• Targeting NRF2 Sensitizes Esophageal Adenocarcinoma Cells to Cisplatin through Induction of Ferroptosis and Apoptosis

  2022cites this paper
• Risk factors for Barrett’s esophagus: Recent advances

  2022cites this paper
• Recurring Translocations in Barrett’s Esophageal Adenocarcinoma

  2021cites this paper
• Unique evolutionary trajectories of breast cancers with distinct genomic and spatial heterogeneity

  2021cites this paper
• Predicting Colorectal Cancer Occurrence in IBD

  2021cites this paper
• Somatic whole genome dynamics of precancer in Barrett’s esophagus reveals features associated with disease progression

  2021cites this paper
• Persistent or recurrent Barrett’s neoplasia after an endoscopic therapy session is associated with DNA content abnormality and can be detected by DNA flow cytometric analysis of paraffin-embedded tissue

  2021cites this paper
• Genomic and Epigenomic Landscaping Defines New Therapeutic Targets for Adenosquamous Carcinoma of the Pancreas

  2020cites this paper
• Towards screening Barrett’s oesophagus: current guidelines, imaging modalities and future developments

  2020cites this paper
• The Magnifying GLASS: Longitudinal Analysis of Adult Diffuse Gliomas.

  2020cites this paper
• Association between p73 gene G4C14-to-A4T14 polymorphism and risk of lung cancer: A meta-analysis.

  2020cites this paper
• Genomic landscape of allelic imbalance in premalignant atypical adenomatous hyperplasias of the lung

  2019cites this paper
• The cyclical hit model: how paligenosis might establish the mutational landscape in Barrett's esophagus and esophageal adenocarcinoma.

  2019cites this paper
• COMPUTATIONAL GENOMIC MODELS FOR SPATIO-TEMPORAL INVESTIGATION OF EARLY LUNG CANCER PATHOLOGY

  2019cites this paper
• Epidemiology of Barrett Esophagus and Risk Factors for Progression

  2019cites this paper
• Complex structural rearrangements are present in high-grade dysplastic Barrett’s oesophagus samples

  2019cites this paper
• Endobrachyœsophage

  2019cites this paper
• 1 The Role of Aneuploidy in Cancer Evolution

  2018cites this paper
• Near‐tetraploid cancer cells show chromosome instability triggered by replication stress and exhibit enhanced invasiveness

  2018cites this paper
• Development of biomarkers for the risk stratification and targeted therapy of Barrett's oesophagus and oesophageal adenocarcinoma

  2018cites this paper
• Molecular Evolution of Metaplasia to Adenocarcinoma in the Esophagus

  2018cites this paper
• A systematic review of epigenetic biomarkers in progression from non-dysplastic Barrett’s oesophagus to oesophageal adenocarcinoma

  2018cites this paper
• University of Birmingham A systematic review of epigenetic biomarkers in progression from non-dysplastic Barrett’s oesophagus to oesophageal adenocarcinoma

  2018cites this paper
• Origins of Metaplasia in the Esophagus: Is This a GE Junction Stem Cell Disease?

  2018cites this paper
• Title Transcriptional dynamics of immortalized humanmesenchymal stem cells during transformation

  2018cites this paper
• Genomics, Endoscopy, and Control of Gastroesophageal Cancers: A Perspective

  2017cites this paper
• The Role of Aneuploidy in Cancer Evolution.

  2017cites this paper
• Epigenetic biomarkers in gastrointestinal cancers: The current state and clinical perspectives

  2017cites this paper
• PET/Computed Tomography Scanning and Precision Medicine: Esophageal Cancer.

  2017cites this paper
• Evolutionary dynamics in pre-invasive neoplasia.

  2017cites this paper
• The Evolving Genomic Landscape of Barrett's Esophagus and Esophageal Adenocarcinoma.

  2017cites this paper
• Molecular clonality analysis of esophageal adenocarcinoma by multiregion sequencing of tumor samples

  2017cites this paper
• On the progression of Barrett's oesophagus to Barrett's adenocarcinoma

  2017influential citation
• Evolution of Premalignant Disease.

  2017cites this paper
• The potential role of statins in the treatment and prevention of oesophageal adenocarcinoma

  2017cites this paper
• Meta‐analysis of biomarkers predicting risk of malignant progression in Barrett's oesophagus

  2017cites this paper
• Mechanisms that drive inflammatory tumor microenvironment, tumor heterogeneity, and metastatic progression.

  2017cites this paper
• Esophageal Cancer Biomarkers

  2017cites this paper
• Extensive telomere erosion is consistent with localised clonal expansions in Barrett’s metaplasia

  2017cites this paper
• Disseminated tumour cells with highly aberrant genomes are linked to poor prognosis in operable oesophageal adenocarcinoma

  2017cites this paper
• Dynamic clonal equilibrium and predetermined cancer risk in Barrett's oesophagus

  2016cites this paper
• Studying Cancer Evolution in Barrett's Esophagus and Esophageal Adenocarcinoma.

  2016cites this paper
• The Role of the p53 Protein in Stem-Cell Biology and Epigenetic Regulation.

  2016cites this paper
• Risk prediction in Barrett’s esophagus – aspects of a combination of molecular and epidemiologic biomarkers reflecting alterations of the microenvironment

  2016cites this paper
• Title Accumulation of Somatic Mutations in TP53 in Gastric Epithelium With�Helicobacter pylori Infection

  2016cites this paper
• Stem Cells, Pre-neoplasia, and Early Cancer of the Upper Gastrointestinal Tract

  2016cites this paper
• Cell autonomous and microenvironmental regulation of tumor progression in precursor states of multiple myeloma

  2016cites this paper
• Surrogate Markers: Lessons from the Next Gen?

  2016cites this paper
• Clonal Evolution in Multiple Myeloma.

  2016cites this paper
• The Complex, Clonal, and Controversial Nature of Barrett's Esophagus.

  2016cites this paper
• Prevention of DNA damage in Barrett's esophageal cells exposed to acidic bile salts.

  2016cites this paper
• How Do Mutant Clones Expand in Normal Tissue

  2016cites this paper
• Chemoprevention of Barrett’s Esophagus and Adenocarcinoma

  2016cites this paper
• Diagnostic Applications of Nuclear Medicine: Esophageal Cancers

  2016cites this paper
• Epigenetics in Obesity and Esophageal Cancer

  2016cites this paper
• Genetic and Epigenetic Alterations in Barrett's Esophagus and Esophageal Adenocarcinoma.

  2015cites this paper
• Cancer: Disease of the age

  2015cites this paper
• The road to cure in multiple myeloma starts with smoldering disease

  2015cites this paper
• Chemoprevention in Barrett's Esophagus: Current Status.

  2015cites this paper
• Chemoprevention in Barrett's oesophagus.

  2015cites this paper
• Aberrant TP53 detected by combining immunohistochemistry and DNA‐FISH improves Barrett's esophagus progression prediction: A prospective follow‐up study

  2015cites this paper
• Barrett oesophagus: lessons on its origins from the lesion itself

  2015cites this paper
• Susceptibilidad genética al cáncer gástrico y lesiones precursoras, y mecanismos moleculares que intervienen en la progresión de la metaplasia intestinal

  2015cites this paper
• Correction: Transcriptional Dynamics of Immortalized Human Mesenchymal Stem Cells during Transformation

  2015cites this paper
• Genomic amplification of 9p24.1 targeting JAK2, PD-L1, and PD-L2 is enriched in high-risk triple negative breast cancer

  2015cites this paper
• Transcriptional Dynamics of Immortalized Human Mesenchymal Stem Cells during Transformation

  2015cites this paper
• Derivation of genetic biomarkers for cancer risk stratification in Barrett’s oesophagus: a prospective cohort study

  2015cites this paper
• A Multiscale Model Evaluates Screening for Neoplasia in Barrett’s Esophagus

  2015cites this paper
• 52. Barrett Esophagus and Esophageal Adenocarcinoma

  2015cites this paper
• Genetic Insights in Barrett's Esophagus and Esophageal Adenocarcinoma.

  2015cites this paper
• Systems Biology of Cancer: Genomic instability and carcinogenesis

  2015cites this paper
• Obesity and increased risk of esophageal adenocarcinoma

  2015cites this paper
• Expression of p 53 and Ki-67 in distal oesophageal and gastric cardia adenocarcinomas

  2015cites this paper
• Exploring the Mechanisms of Gastrointestinal Cancer Development Using Deep Sequencing Analysis

  2015cites this paper
• Review of genomics of Barrett's esophagus and esophageal

  2015cites this paper
• Multiscale Modeling of Esophageal Adenocarcinoma

  2015cites this paper
• Cancer Treatment Strategies

  2014cites this paper
• Genomic DNA copy number alterations from precursor oral lesions to oral squamous cell carcinoma.

  2014cites this paper
• Die Einnahme eines Statins reduziert das Risiko für einen Barrett-Ösophagus

  2014cites this paper
• How I Treat How I treat smoldering multiple myeloma

  2014cites this paper
• METHOD Open Access

  2014cites this paper
• Molecular epidemiology of and genetic susceptibility to esophageal cancer

  2014cites this paper
• Epigenetic biomarkers in esophageal cancer.

  2014cites this paper
• The '–omics' revolution and oesophageal adenocarcinoma

  2014cites this paper
• Is carcinogenesis in Barrett ’ s esophagus a clonal evolution ?

  2014cites this paper
• Prediction of response to endoscopic therapy of Barrett's dysplasia by using genetic biomarkers.

  2014cites this paper
• Multi-colour FISH in oesophageal adenocarcinoma—predictors of prognosis independent of stage and grade

  2014cites this paper
• APLIKASI SITOGENETIKA UNTUK MENDETEKSI ABNORMALITAS KROMOSOM PADA Benign Barrett's EPITHELIUM YANG MENGALAMI TRANSFORMASI MALIGNA

  2014cites this paper
• How I treat smoldering multiple myeloma.

  2014cites this paper
• Accumulation of somatic mutations in TP53 in gastric epithelium with Helicobacter pylori infection.

  2014cites this paper